Teva Pharmaceuticals Competitors and Similar CompaniesClear all
Viatris's competitors and similar companies include Novartis, AstraZeneca and Allergan.
 Viatris Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. |  Allergan Allergan is a healthcare company focused on developing, manufacturing, and commercializing branded pharmaceutical, device, biologic, surgical, and regenerative medicine products. | |
Founding Date | Founding Date 2020 | Founding Date 1996 | Founding Date 1999 | Founding Date 1948 |
Type | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Canonsburg, US HQ Carole Park, AU Millers Point, AU Campos Dos Goytacazes, BR São Paulo, BR Sofia, BG Toronto, CA see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations Dublin, IE HQ Buenos Aires, AR Roseville, AU Machelen, BE Guarulhos, BR Las Condes, CL Bogotá, CO see more |
Employees | Employees 38,0003% increase | Employees 75,883 | Employees 94,300 | Employees 10,5471% decrease |
Valuation ($) | Valuation ($) 14 b | Valuation ($) N/A | Valuation ($) 2.7 b | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $14.3b (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $9.3b (FY, 2025) | Cost of goods $8.4b (FY, 2025) | Cost of goods $4.9b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $5b (FY, 2025) | Gross profit $49.8b (FY, 2025) | Gross profit $54.2b (FY, 2025) | Gross profit N/A |
Net income | Net income ($3.5b) (FY, 2025) | Net income $14b (FY, 2025) | Net income $10.2b (FY, 2025) | Net income N/A |
Operating ⚠ | ||||
Countries | Countries 165 (Q1, 2023) | Countries N/A | Countries 130 (FY, 2021) | Countries 100 (Q1, 2020) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 6.5m | Total funding raised $ 1b | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Novartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyAstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View companyAllergan
HQ
Dublin, IE
Allergan is a healthcare company focused on developing, manufacturing, and commercializing branded pharmaceutical, device, biologic, surgical, and regenerative medicine products.
View company